Pricing & Access· July 15, 2026 · 21 min read
Topic
Respiratory
Asthma, COPD, biologics, inhaled therapy, access criteria, and respiratory drug commercialization.
Pricing & Access· July 15, 2026 · 19 min read
IPF Access Landscape 2026: Jascayd, Ofev Generic entry, and Pirfenidone Pricing
Pricing & Access· July 12, 2026 · 20 min read
Severe Asthma Biologics: Access and Phenotype Matching Guide
By Ran Chen#Payer Coverage#Payer Criteria#Respiratory
Pricing & Access· July 11, 2026 · 16 min read
GSK Portfolio Dossier: ViiV HIV, Nucala Runway, and Oncology Rebuild
By Ran Chen#HIV#Respiratory#Infectious Disease
Pricing & Access· May 27, 2026 · 10 min read
Tezspire coverage guide for severe asthma and CRSwNP
Biosimilars· May 27, 2026 · 11 min read